Boris Reizis
University of Chicago, ILLINOIS, United States
- This delegate is presenting an abstract at this event.
Boris received his PhD at the Weizmann Institute of Science, trained as a postdoc at Harvard Medical School, and subsequently served as a faculty at Columbia University and NYU. In 2025, he joined the University of Chicago as a professor of medicine and a director of the Center for Autoimmunity. His lab is studying mechanisms of immune system development, tolerance and autoimmunity, focusing primarily on dendritic cells. Studies in the lab helped elucidate the transcriptional control of DC lineage, including the differentiation and function of plasmacytoid dendritic cells, Notch2-dependent classical dendritic cells, and most recently, migratory dendritic cells.
Presentations this author is a contributor to:
Transcription factor Etv3 controls the tolerogenic function of dendritic cells (137732)
6:00 PM
Nicholas M Adams
Ralph Steinman Legacy Symposium: Foundational Discoveries that Shaped the Field
Transcription factor Etv3 controls the positioning of mature dendritic cells within the lymph node (#141)
12:30 PM
Daniel C Martinez-Krams
Poster Session 1
Plasmacytoid dendritic cells initiate local type I interferon responses via contact-dependent recognition of infected macrophages (#174)
12:30 PM
Annesa Das
Poster Session 1
Chromatin-mediated control of dendritic cell function (#1)
3:30 PM
Boris Reizis
Inaugural Keynote Speaker
Transcriptional regulation of OX40L expression during dendritic cell maturation (#218)
12:30 PM
Timothy Kung
Poster Session 2
Trim33 is essential for the development and maintenance of plasmacytoid and type 1 conventional dendritic cells (#105)
12:30 PM
Pei-Feng Hsu
Poster Session 1